DarioHealth Corp.: 10-Q filed 2015-11-13
What DarioHealth Corp. reported in its quarterly report filed 2015-11-13 (fiscal Q3 2015): 29 published measures, 92 facts as tagged in accession 0001144204-15-064963.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-13
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001144204-15-064963 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DarioHealth Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 3,550,000 | USD | |
| At 2014-12-31 | 3,081,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -3,960,000 | USD | |
| At 2014-12-31 | -5,295,000 | USD | |
| At 2013-12-31 | -86,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,908,000 | USD | |
| At 2014-12-31 | 1,453,000 | USD | |
| At 2014-09-30 | 4,170,000 | USD | |
| At 2013-12-31 | 2,263,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -1,829,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -5,470,000 | USD | 273 |
| 2014-01-01 to 2014-12-31 | -12,877,000 | USD | 365 |
| 2014-07-01 to 2014-09-30 | -3,077,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -9,315,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 70,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 219,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 273,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 515,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 0 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 0 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -41,682,000 | USD | |
| At 2014-12-31 | -36,058,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 37,433,188 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 29,835,891 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 9,610,160 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 6,179,981 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 37,433,188 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 29,835,891 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 9,610,160 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 6,194,418 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -0.05 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.19 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | -0.66 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -2.03 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -0.05 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.19 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | -0.66 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -2.23 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 796,000 | USD | |
| At 2014-12-31 | 978,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -2,547,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -5,836,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -2,507,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -8,778,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,721,000 | USD | |
| At 2014-12-31 | 2,056,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,527,000 | USD | |
| At 2014-12-31 | 1,616,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 2,416,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 5,240,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 1,922,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 7,167,000 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 315,000 | USD | |
| At 2014-12-31 | 234,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -131,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -596,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -585,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -1,611,000 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 404,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,111,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 585,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,611,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 667,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,991,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 769,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 3,209,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 42,768,309 | shares | |
| At 2014-12-31 | 16,233,430 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 37,718,000 | USD | |
| At 2014-12-31 | 30,761,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 419,000 | USD | |
| At 2014-12-31 | 286,000 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -1,829,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -5,624,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -6,333,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -12,571,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 1,332,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,318,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 901,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 3,047,000 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 248,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 461,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -35,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -11,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -3,176,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -3,681,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 718,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 366,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -570,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -537,000 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 81,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 109,000 | USD | 273 |
Inspect the source
- Entity
- DarioHealth Corp. / CIK 0001533998
- Captured
- 2026-09-20T09:16:34.053Z
- SEC response SHA-256
8c524c61fa46c2531eea7286cfb0614b41c397fc0b2f416d3e5df141148eb6b9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001533998.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))